Reported Earnings • May 15
First quarter 2026 earnings released: EPS: CA$0.01 (vs CA$0.016 loss in 1Q 2025) First quarter 2026 results: EPS: CA$0.01 (up from CA$0.016 loss in 1Q 2025). Revenue: CA$16.6m (down 17% from 1Q 2025). Net income: CA$86.4k (up CA$498.1k from 1Q 2025). Profit margin: 0.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Announcement • Apr 16
Bri-Chem Corp., Annual General Meeting, Jun 19, 2026 Bri-Chem Corp., Annual General Meeting, Jun 19, 2026. Location: british columbia, vancouver Canada Reported Earnings • Mar 27
Full year 2025 earnings released: EPS: CA$0.04 (vs CA$0.15 loss in FY 2024) Full year 2025 results: EPS: CA$0.04 (up from CA$0.15 loss in FY 2024). Revenue: CA$75.6m (down 9.0% from FY 2024). Net income: CA$979.0k (up CA$4.83m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 18
Third quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.01 loss in 3Q 2024) Third quarter 2025 results: EPS: CA$0.01 (up from CA$0.01 loss in 3Q 2024). Revenue: CA$18.2m (down 17% from 3Q 2024). Net income: CA$160.3k (up CA$429.1k from 3Q 2024). Profit margin: 0.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Oct 21
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.3% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Oct 18
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 8.3% to CA$0.22. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Sep 15
Now 24% undervalued Over the last 90 days, the stock has risen 4.7% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Aug 16
Second quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.018 loss in 2Q 2024) Second quarter 2025 results: EPS: CA$0.01 (up from CA$0.018 loss in 2Q 2024). Revenue: CA$20.5m (up 7.5% from 2Q 2024). Net income: CA$156.8k (up CA$644.6k from 2Q 2024). Profit margin: 0.8% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance. Reported Earnings • May 17
First quarter 2025 earnings released: CA$0.02 loss per share (vs CA$0.057 loss in 1Q 2024) First quarter 2025 results: CA$0.02 loss per share (improved from CA$0.057 loss in 1Q 2024). Revenue: CA$19.9m (down 6.8% from 1Q 2024). Net loss: CA$411.8k (loss narrowed 73% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance. Announcement • Apr 16
Bri-Chem Corp., Annual General Meeting, Jun 20, 2025 Bri-Chem Corp., Annual General Meeting, Jun 20, 2025. Location: alberta, edmonton Canada Reported Earnings • Apr 01
Full year 2024 earnings released: CA$0.15 loss per share (vs CA$0.034 profit in FY 2023) Full year 2024 results: CA$0.15 loss per share (down from CA$0.034 profit in FY 2023). Revenue: CA$83.1m (down 22% from FY 2023). Net loss: CA$3.85m (down CA$4.76m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 17
Third quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 3Q 2023) Third quarter 2024 results: CA$0.01 loss per share (improved from CA$0.014 loss in 3Q 2023). Revenue: CA$22.0m (down 18% from 3Q 2023). Net loss: CA$268.8k (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 16
Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.021 profit in 2Q 2023) Second quarter 2024 results: CA$0.02 loss per share (down from CA$0.021 profit in 2Q 2023). Revenue: CA$19.1m (down 24% from 2Q 2023). Net loss: CA$487.8k (down 188% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Reported Earnings • May 19
First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.01 profit in 1Q 2023) First quarter 2024 results: CA$0.06 loss per share (down from CA$0.01 profit in 1Q 2023). Revenue: CA$21.4m (down 21% from 1Q 2023). Net loss: CA$1.51m (down CA$1.77m from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 16% per year. Announcement • Apr 09
Bri-Chem Corp., Annual General Meeting, Jun 20, 2024 Bri-Chem Corp., Annual General Meeting, Jun 20, 2024. New Risk • Apr 01
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 30% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.91m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Reported Earnings • Apr 01
Full year 2023 earnings released: EPS: CA$0.03 (vs CA$0.33 in FY 2022) Full year 2023 results: EPS: CA$0.03 (down from CA$0.33 in FY 2022). Revenue: CA$106.0m (up 1.5% from FY 2022). Net income: CA$909.4k (down 90% from FY 2022). Profit margin: 0.9% (down from 8.3% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Board Change • Jan 09
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 17
Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.019 profit in 3Q 2022) Third quarter 2023 results: CA$0.01 loss per share (down from CA$0.019 profit in 3Q 2022). Revenue: CA$26.8m (down 7.4% from 3Q 2022). Net loss: CA$375.8k (down 175% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 76% per year whereas the company’s share price has increased by 77% per year. Reported Earnings • Aug 16
Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.014 in 2Q 2022) Second quarter 2023 results: EPS: CA$0.02 (up from CA$0.014 in 2Q 2022). Revenue: CA$25.2m (flat on 2Q 2022). Net income: CA$552.9k (up 62% from 2Q 2022). Profit margin: 2.2% (up from 1.3% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 74% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 17
First quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.33 in 1Q 2022) First quarter 2023 results: EPS: CA$0.01 (down from CA$0.33 in 1Q 2022). Revenue: CA$27.2m (up 16% from 1Q 2022). Net income: CA$265.2k (down 97% from 1Q 2022). Profit margin: 1.0% (down from 33% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 82% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 31
Full year 2022 earnings released: EPS: CA$0.33 (vs CA$0.055 in FY 2021) Full year 2022 results: EPS: CA$0.33 (up from CA$0.055 in FY 2021). Revenue: CA$104.5m (up 73% from FY 2021). Net income: CA$8.64m (up CA$7.33m from FY 2021). Profit margin: 8.3% (up from 2.2% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 16
Third quarter 2022 earnings released: EPS: CA$0.02 (vs CA$0.015 in 3Q 2021) Third quarter 2022 results: EPS: CA$0.02 (up from CA$0.015 in 3Q 2021). Revenue: CA$29.0m (up 76% from 3Q 2021). Net income: CA$499.9k (up 44% from 3Q 2021). Profit margin: 1.7% (down from 2.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 16
Second quarter 2022 earnings released: EPS: CA$0.014 (vs CA$0.002 in 2Q 2021) Second quarter 2022 results: EPS: CA$0.014 (up from CA$0.002 in 2Q 2021). Revenue: CA$25.5m (up 83% from 2Q 2021). Net income: CA$341.1k (up CA$296.8k from 2Q 2021). Profit margin: 1.3% (up from 0.3% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 68% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 18
First quarter 2022 earnings released: EPS: CA$0.32 (vs CA$0.006 in 1Q 2021) First quarter 2022 results: EPS: CA$0.32 (up from CA$0.006 in 1Q 2021). Revenue: CA$23.5m (up 105% from 1Q 2021). Net income: CA$7.77m (up CA$7.63m from 1Q 2021). Profit margin: 33% (up from 1.2% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Apr 14
Bri-Chem Corp., Annual General Meeting, Jun 14, 2022 Bri-Chem Corp., Annual General Meeting, Jun 14, 2022. Reported Earnings • Apr 01
Full year 2021 earnings released: EPS: CA$0.06 (vs CA$0.21 loss in FY 2020) Full year 2021 results: EPS: CA$0.06 (up from CA$0.21 loss in FY 2020). Revenue: CA$60.4m (up 34% from FY 2020). Net income: CA$1.32m (up CA$6.46m from FY 2020). Profit margin: 2.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 20
Third quarter 2021 earnings released: EPS CA$0.015 (vs CA$0.078 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$16.5m (up 121% from 3Q 2020). Net income: CA$347.8k (up CA$2.21m from 3Q 2020). Profit margin: 2.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 14
Second quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.053 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CA$13.9m (up 104% from 2Q 2020). Net income: CA$44.2k (up CA$1.32m from 2Q 2020). Profit margin: 0.3% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 03
Full year 2020 earnings released: CA$0.22 loss per share (vs CA$0.15 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CA$45.2m (down 51% from FY 2019). Net loss: CA$5.15m (loss widened 41% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 35% per year whereas the company’s share price has fallen by 36% per year. Reported Earnings • Nov 15
Third quarter 2020 earnings released: CA$0.08 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: CA$7.45m (down 66% from 3Q 2019). Net loss: CA$1.86m (loss widened CA$1.69m from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings. Announcement • Oct 07
Bri-Chem Corp. Appoints Tony Pagnucco as Chief Financial Officer, Effective October 6, 2020 Bri-Chem Corp. announced that Tony Pagnucco, CPA, has been appointed Chief Financial Officer, effective October 6, 2020. Mr. Pagnucco will succeed Jason Theiss, who will be stepping down from the CFO role on October 31, 2020 to pursue other interests. 
